222 related articles for article (PubMed ID: 25557171)
21. CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.
Xu B; Zhou M; Qiu W; Ye J; Feng Q
Cancer Med; 2017 May; 6(5):1062-1071. PubMed ID: 28378417
[TBL] [Abstract][Full Text] [Related]
22. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
[TBL] [Abstract][Full Text] [Related]
23. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney.
Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917
[TBL] [Abstract][Full Text] [Related]
24. Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.
Cronan MR; Nakamura K; Johnson NL; Granger DA; Cuevas BD; Wang JG; Mackman N; Scott JE; Dohlman HG; Johnson GL
Oncogene; 2012 Aug; 31(34):3889-900. PubMed ID: 22139075
[TBL] [Abstract][Full Text] [Related]
25. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
26. TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis.
Iriondo O; Liu Y; Lee G; Elhodaky M; Jimenez C; Li L; Lang J; Wang P; Yu M
Nat Commun; 2018 May; 9(1):1994. PubMed ID: 29777109
[TBL] [Abstract][Full Text] [Related]
27. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
[TBL] [Abstract][Full Text] [Related]
28. Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.
An J; Liu H; Magyar CE; Guo Y; Veena MS; Srivatsan ES; Huang J; Rettig MB
Cancer Res; 2013 Feb; 73(4):1374-85. PubMed ID: 23393199
[TBL] [Abstract][Full Text] [Related]
29. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ
Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of transforming growth factor-β-activated kinase 1 promotes taxol efficacy in ovarian cancer cells.
Bo L; Cui H; Fang Z; Qun T; Xia C
Biomed Pharmacother; 2016 Dec; 84():917-924. PubMed ID: 27764753
[TBL] [Abstract][Full Text] [Related]
31. Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation.
Moreno-García ME; Sommer K; Rincon-Arano H; Brault M; Ninomiya-Tsuji J; Matesic LE; Rawlings DJ
Mol Cell Biol; 2013 Mar; 33(6):1149-63. PubMed ID: 23297344
[TBL] [Abstract][Full Text] [Related]
32. TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells.
Safina A; Sotomayor P; Limoge M; Morrison C; Bakin AV
Mol Cancer Res; 2011 Aug; 9(8):1042-53. PubMed ID: 21700681
[TBL] [Abstract][Full Text] [Related]
33. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
[TBL] [Abstract][Full Text] [Related]
34. TAK1 signaling activity links the mast cell cytokine response and degranulation in allergic inflammation.
Watson CJF; Maguire ARR; Rouillard MM; Crozier RWE; Yousef M; Bruton KM; Fajardo VA; MacNeil AJ
J Leukoc Biol; 2020 Apr; 107(4):649-661. PubMed ID: 32108376
[TBL] [Abstract][Full Text] [Related]
35. TAK1-binding protein 1, TAB1, mediates osmotic stress-induced TAK1 activation but is dispensable for TAK1-mediated cytokine signaling.
Inagaki M; Omori E; Kim JY; Komatsu Y; Scott G; Ray MK; Yamada G; Matsumoto K; Mishina Y; Ninomiya-Tsuji J
J Biol Chem; 2008 Nov; 283(48):33080-6. PubMed ID: 18829460
[TBL] [Abstract][Full Text] [Related]
36. PGC-1β suppresses saturated fatty acid-induced macrophage inflammation by inhibiting TAK1 activation.
Chen H; Liu Y; Li D; Song J; Xia M
IUBMB Life; 2016 Feb; 68(2):145-55. PubMed ID: 26748475
[TBL] [Abstract][Full Text] [Related]
37. TAK1 is required for TGF-beta 1-mediated regulation of matrix metalloproteinase-9 and metastasis.
Safina A; Ren MQ; Vandette E; Bakin AV
Oncogene; 2008 Feb; 27(9):1198-207. PubMed ID: 17828308
[TBL] [Abstract][Full Text] [Related]
38. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation.
Yang CY; Li JP; Chiu LL; Lan JL; Chen DY; Chuang HC; Huang CY; Tan TH
J Immunol; 2014 Feb; 192(4):1547-57. PubMed ID: 24403530
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.
Pan MR; Hou MF; Chang HC; Hung WC
J Biol Chem; 2008 Apr; 283(17):11155-63. PubMed ID: 18319253
[TBL] [Abstract][Full Text] [Related]
40. Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line Daudi.
Zhang J; Li B; Wu H; Ou J; Wei R; Liu J; Cai W; Liu X; Zhao S; Yang J; Zhou L; Liu S; Liang A
Tumour Biol; 2016 Jan; 37(1):531-9. PubMed ID: 26227222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
